Poland· PL-100502185
Eplerenonum + Furosemidum LEK-AM
A furosemid und kaliumsparende diuretika product containing eplerenonum + furosemidum, registered in Poland by Przedsiębiorstwo Farmaceutyczne LEK-AM Sp. z o.o.. The same ATC class is registered in 6 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Furosemid und kaliumsparende diuretika is registered in 6 of 19 countries.
Countries holding a registration under ATC C03EB01 (furosemid und kaliumsparende diuretika), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
Furosemid und kaliumsparende diuretika · ATC C03EB01
6 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Ireland
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Eplerenonum + Furosemidum
- Manufacturer
- Przedsiębiorstwo Farmaceutyczne LEK-AM Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- C03EB01
- ATC class
- Furosemid und kaliumsparende Diuretika
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05906720538128
- gtin05906720538142
- gtin05909991567613
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
6 interactions on record for furosemid und kaliumsparende diuretika.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Furosemid und kaliumsparende diuretika · interactions on record
6 records
6 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under C03EB01
Furosemid und kaliumsparende diuretika, as other registers publish it.
- PolandEplerenonum + Furosemidum LEK-AMPrzedsiębiorstwo Farmaceutyczne LEK-AM Sp. z o.o.
- IrelandFrumil 40mg/5mg TabletsSanofi-Aventis Ireland Limited T/A SANOFI
- DenmarkFrusamil2care4 ApS
- DenmarkFrusamilOrifarm A/S
- BelgiumFrusamil 5 mg - 40 mgSanofi Belgium
- FinlandFuresis CompOrion Corporation
- FinlandFuresis Comp MiteOrion Corporation Orion Pharma
- FinlandFuromex CompOrion Corporation Orion Pharma
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/66158878-0680-4e93-860b-f9656e787886 GET /v1/drugs/66158878-0680-4e93-860b-f9656e787886?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "25 mg + 40 mg",
"packaging": "05909991567613 ¦ Rp ¦ 160713\n30 tabl.\n05906720538128 ¦ Rp ¦ 165155\n60 tabl.\n05906720538142 ¦ Rp ¦ 165156\n90 tabl.",
"substance": "Eplerenonum 25 mg + Furosemidum 40 mg",
"common_name": "Eplerenonum + Furosemidum",
"pl_product_id": "100502185",
"pozwolenie_nr": "28927",
"auth_procedure": "NAR",
"authorisation_validity": "2030-03-24"
}See everything about furosemid und kaliumsparende diuretika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.